The goal of this proposed research is to assess the preliminary efficacy of dietary
interventions that change dietary fats in improving clinical outcomes related to lumbar
radicular pain. After a two-week baseline, consented participants are randomized to one of
two diets. Key foods consistent with the diet are provided for 12 weeks along with extensive
dietary counseling and support from the study-provided materials. Participants are
encouraged to follow the assigned diet for another 6 weeks without provision of food.
Participants complete questionnaires at baseline, randomization, and after 6 weeks, 12
weeks, and 18 weeks on the diet. They provide blood samples at randomization (2 weeks) and
after 12 and 18 weeks on the diet.
Lumbar radiculopathy is a fairly common pain syndrome which may result in chronic, severe
disability. There are few successful treatment options for patients with persistent
lumbosacral radicular pain (LRP) that does not respond to conventional approaches. A
fundamental biologic mechanism of chronic LRP, as well as other chronic pain syndromes, may
involve failure of inflammation-resolution, an active process driven by lipid mediators
derived from fatty acids (resolvins, protectins, maresins). The investigators' preliminary
studies indicate that dietary modifications, specifically increasing some dietary fatty
acids, while reducing others, result in large, statistically significant and clinically
relevant improvement in headache frequency, intensity, and other clinical outcomes in
community dwelling persons with chronic headaches.
The proposed trial represents a promising approach to treatment of a disabling condition,
lumbar radiculopathy. The previous headache trial by the investigators' interdisciplinary
UNC/NIH team demonstrated that specific dietary manipulations can produce marked biochemical
changes and have a major positive clinical impact. This project promises to enhance the
generalizability of the investigators' approach by expanding from chronic headaches to
another common chronic pain condition, and also by using a more cost-effective intervention.
Because dietary modification is a relatively safe and low-cost health-improvement strategy,
the long-term outcome of this research may be to empower individuals to take a more active
role in their own health through dietary changes that reduce dependence on medical
treatments, while providing significant clinical benefits.
Baseline Phase. Medical records will be obtained for the participant's history and physical
examination (performed by referring physician at the Spine Center). The baseline visit will
consist of review of inclusion/exclusion criteria and the components of the study prior to
consenting. Those who wish to sign the consents will complete baseline assessment
instruments that measure lumbosacral radiculopathy characteristics and their impact on
quality-of-life. Through electronic diaries, participants will provide daily data on pain
intensity, duration, function, sleep quality, and medication use over a 2-week baseline
phase. Participants who are compliant with all aspects of data collection, and who
experience daily radicular pain, will be eligible for study intervention participation.
Randomization. At the end of the 2-week baseline phase, participants who qualify will be
randomized (computer-generated variable permuted block) to: 1) the High n-3, Low n-6 Diet
(Analgesic Diet); or 2) the Control Diet. Blood will be collected for baseline biomarker
assessment prior to beginning study diets.
Post Randomization. After randomization, participants will attend an initial, in-depth
dietary counseling session administered by the registered dietitian. Participants will be
asked to provide a dietary history and will receive detailed instruction in the specific
dietary intervention per group assignment. Participants in each group will attend a total of
3 in-person follow-up sessions with the dietitian, for review of their dietary experiences,
to receive encouragement, to clarify issues, and to have questions answered. At each visit,
the dietitian will obtain a dietary history and assessment, provide tailored counseling, and
record data for evaluation of participant variability in order to guide future sessions.
Participants will have a visit with the dietitian at randomization, two weeks later, 4 weeks
after that, and 6 weeks after that (at the end of the intervention). In addition,
individuals will participate in brief (15-20 minute) check-in telephone calls with the
dietitian every 2-3 weeks. Participants will have contact with the research assistant twice
weekly to encourage diary completion and to invite adverse event reporting.
During the 12-week intervention phase (weeks 2-14), participants will be provided with
essential foods to enable them to follow diet recommendations, including study oils, salad
dressings, and unprepared protein sources (meat, beans, fish). For the remainder of their
meals, participants will choose food products consistent with their assigned diet. At the
conclusion of the post-intervention phase (Week 20, Diet week 18), participants will
complete on-line questionnaires and provide blood samples. The purpose of this
post-intervention phase is: 1) to obtain pilot data on the ability of participants to
continue to achieve nutrient intake targets without counseling and food provision; and 2) to
obtain pilot data on the post-intervention trajectory of biochemical and clinical outcomes.
Throughout the 12-week active intervention and the 6-week post-intervention phases,
participants will have access to detailed intervention materials. Diet education materials
include the diet guidelines, allowed food list, how to read food labels, grocery shopping
guides for 9 local grocery stores, dining out guide, 7-day meal plan and 75 recipes with the
ability for the dietitian to add more.
Food Supply. Participants will visit the dietitian 3 times during the 12-week active
intervention to obtain specific food items with targeted nutrient compositions. Food items
will include: cooking oils, salad dressings, mayonnaise, portable dressing packets,
unprepared frozen food items, and key ingredients for home preparation of meals and snacks.
All foods have been specifically selected to ensure that participants meet specific nutrient
intake targets. Prior nutrient analyses of more than 80 relevant food items was performed as
part of the investigators' previous dietary intervention study in participants with chronic
daily headache, by the National Institutes of Health-National Institute on Alcohol Abuse and
Alcoholism Section of Nutritional Neurosciences (SNN). The SNN has agreed to provide further
nutrient analysis as needed for the proposed study.
Assessments. Throughout the 2-week baseline, the 12-week active intervention, and 6-week
post-intervention phases, all participants will record pain intensity, pain interference,
medication use, activity, and stress using a daily pain diary accessed by mobile device.
Blood samples will be collected during three visits at the end of the baseline phase (Week
2, Diet week 0) and then at study Weeks 14 and 20 (at the end of the active intervention and
at the end of the post-intervention period) for nutritional and metabolic biomarker
measurement. At each sample collection visit (and after 6 weeks on the diet), participants
will also complete the Oswestry Disability Index (ODI) and NIH PROMIS-29 battery (physical
function, anxiety, depression, fatigue, sleep disturbance, satisfaction with social role,
pain interference, pain intensity). Every 6 weeks, participants will also be asked about
their use of other modalities for pain control, including physical therapy, spinal
manipulation, epidural corticosteroid injections, acupuncture, and yoga.
Interventions. All participants will receive: 1) tailored dietitian-administered counseling
consistent with the group assignment; 2) access to intervention-specific informational
materials and daily outcome assessments; and 3) critical food items with precisely
quantified fatty acid composition, selected to meet nutrient intake targets specific for
each of the assignment groups.
Random Allocation. At the first intervention visit, At Week 2, the research dietitian will
enter the participant's assigned ID into an online computer program that will determine
assignment to one of the two diets. Using a random number sequence to generate a permuted
block of 2-4, the program ensures equal numbers of participants in each arm. The program
documents treatment assignment in an un-editable form including a date stamp.
Masking. The research staff, masked to treatment assignment, will schedule all study-related
visits in the Clinical and Translational Research Center (CTRC) or other appropriate site in
the University of North Carolina (UNC) Healthcare system or medical school. Only the
dietitian will, of necessity, be unmasked. All investigators and laboratory personnel will
be masked to dietary assignment. Masking will be maintained in the random allocation
procedure. The research dietitian will not indicate to participants which diets are
considered to be treatment diets vs. the control diet.
MRI-verified lumbosacral radiculopathy associated with herniated disc, spinal stenosis, or
- Pain reaching to the knee for at least 12 weeks
- Willing to complete daily diary for 20 weeks, as evidenced by completion of ≥12 of
the first 14 days
- Possessing a mobile device (smart phone, tablet, laptop) capable of accessing the
application and website
- Able to attend dietitian counseling sessions in Chapel Hill, NC
- Under care of a physician for LR
- Able to read and communicate in English
- Psychosis or severe depression, anxiety, substance abuse disorder
- History of specific food allergies that would prevent adherence to study diet
- Aversion to eating fish
- Currently taking fish oil or other supplements that contain fatty acids under
- Pregnancy or anticipated pregnancy
- Active treatment for a major medical illness, such as malignancy, autoimmune, immune
- History of vasculitis, intracranial mass, clotting disorder (including
medication-induced, e.g., warfarin)
- Cognitive dysfunction preventing informed consent
- Pending personal injury litigation, including worker's compensation
- Chronic long-term disability related to lumbosacral injury/symptoms